UroLift System With SAbR for Prostate Cancer and BPH

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 11, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Prostate Cancer

Interventions

DEVICE

Urolift

Urolift Implant

RADIATION

SABR

Stereotactic Body Radiation Therapy for prostate cancer

Trial Locations (1)

University of Texas Southwestern Medical Center - Dallas, Dallas

All Listed Sponsors

collaborator

NeoTract, Inc.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER